about
Molecular characterization and evolution of the SPRR family of keratinocyte differentiation markers encoding small proline-rich proteinsLumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression.Runx1 is a tumor suppressor gene in the mouse gastrointestinal tract.Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer.High Prevalence and Clinical Relevance of Genes Affected by Chromosomal Breaks in Colorectal Cancer.MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients.Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectumThe Melanoma MAICare Framework: A Microsimulation Model for the Assessment of Individualized Cancer Care.CFTR is a tumor suppressor gene in murine and human intestinal cancerThe roles of sPLA2-IIA (Pla2g2a) in cancer of the small and large intestine.Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer.Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis.Lumican and versican are associated with good outcome in stage II and III colon cancer.The potential of imaging techniques as a screening tool for colorectal cancer: a cost-effectiveness analysis.The role of KCNQ1 in mouse and human gastrointestinal cancers.Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients.Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers.Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.Proteomics of differential extraction fractions enriched for chromatin-binding proteins from colon adenoma and carcinoma tissues.Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression.Identification of differentially expressed splice variants by the proteogenomic pipeline Splicify.GeneBreak: detection of recurrent DNA copy number aberration-associated chromosomal breakpoints within genes.Collagen-rich stroma in aggressive colon tumors induces mesenchymal gene expression and tumor cell invasion.Molecular imaging of aurora kinase A (AURKA) expression: Synthesis and preclinical evaluation of radiolabeled alisertib (MLN8237).Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence.Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9.Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice.Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.Complexity of lung cancer modifiers: mapping of thirty genes and twenty-five interactions in half of the mouse genome.TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.Direct detection of early-stage cancers using circulating tumor DNA.tranSMART.Systematically linking tranSMART, Galaxy and EGA for reusing human translational research data.Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control Study.Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases.Expression of Pla2g2a prevents carcinogenesis in Muc2-deficient mice.Paving the road towards non-invasive molecular imaging.A gene for susceptibility to small intestinal cancer, ssic1, maps to the distal part of mouse chromosome 4.
P50
Q24309192-894CF4E3-23B8-456E-9C47-8AA30C38BB12Q33648190-0CDBAFED-06C8-4395-A17C-DC84708229B0Q33711292-A04350D4-D74D-4CD2-AE52-FD126B99CCBDQ34051967-7D446474-601B-47E5-96BF-FADC9BCA43B1Q34165054-4F63C553-3F7F-49FC-8934-AD93754CF16AQ35777233-45E336B9-13DB-4491-BBE0-9D842F13511FQ36413436-EA114141-4ED3-4720-9C2A-574C44EF2ADCQ36579500-EE7338E5-0139-4D80-971E-E7AB3B7E3E50Q37016576-8AA50A5F-AEE2-4BBD-B958-A330C0E03231Q37083588-BB66B4D6-0329-4144-AE14-46DCBD71D0AFQ37175257-0210DF59-7D2D-4BFF-AD72-387430AE10A1Q37182264-6921088B-4A22-4982-828D-329141ADB6D2Q37279302-0AFF81AD-9FDF-403D-B408-A40D3F5031EFQ37379954-8BCB41FD-8851-4AE5-A24D-306DC1CD70F3Q37600878-0DC3E4CA-67F6-4A79-B157-1D781A9F7553Q37605301-F8FFAA9C-6D5B-4D64-8F25-AA9CBB532A69Q37687487-6FC4004C-35EE-49FD-88B6-63FACF8A9F01Q37769958-775630B1-3154-4913-9504-0545D12A1E45Q38060396-366B6DA9-B77F-4377-9EAC-4C1A8D8765F9Q38481848-F61AA631-82E0-4D87-BBD4-44484BECE253Q38507628-325CF828-7A32-4B57-8449-273EFC86FB39Q38659439-4DB05A9B-4782-4B2F-9530-ED91CF2D8BD2Q38676455-B1B2F5AF-FB22-408A-996E-17797F1CA3F5Q38784679-6DA872C8-4E67-4F92-9564-CB139C685914Q38830609-6C183D34-3609-4599-A483-75BDE4EBA475Q39180723-294B3390-72CF-459B-B18B-5C65FA8CC07FQ39479646-7021ED4F-8191-4F18-8482-700414498705Q39627905-0C72B26D-F15C-43C7-A2EF-798AB266850FQ39961306-BF98330F-87C0-470F-8798-25C38F3D0A4DQ41352188-0B13ED2A-0371-4240-83C0-45E9534C495EQ43754832-D6FBEFBE-5BE4-4818-B954-C66EE9BCD59DQ45216328-0F2EDDAC-4CAD-4074-AC20-976801517535Q46035548-405E8F14-5F13-4374-A29C-FE4479F3CA63Q46042831-08A55E90-0BA7-4B2A-BA6F-672F80350C46Q46264375-1CDBA99B-F5C6-445D-A8CC-A14BB67F1005Q47211286-03380E68-E7FB-47D4-9051-822107063B40Q48229350-B1AF076C-750E-47B4-8DD9-A50EF45B9798Q51672179-9F3BAE4F-607F-41D9-8E1D-D98DE5D4AD6CQ54146433-0AF3E81E-7440-46BB-8DAB-C2D87FA8DF93Q54167640-5479889D-AE73-4B1B-B631-53EEA0ED9BE0
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Remond Fijneman
@ast
Remond Fijneman
@en
Remond Fijneman
@es
Remond Fijneman
@nl
type
label
Remond Fijneman
@ast
Remond Fijneman
@en
Remond Fijneman
@es
Remond Fijneman
@nl
prefLabel
Remond Fijneman
@ast
Remond Fijneman
@en
Remond Fijneman
@es
Remond Fijneman
@nl
P106
P31
P496
0000-0003-2076-5521